Amgen saw the highest growth of 104% in patent filings in March and 98% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 98% and grants by 92%. GlobalData’s DataBook provides a comprehensive analysis of Amgen‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Amgen has been focused on protecting inventions in United States(US) with 109 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 19% filings and 21% grants. The United States(US), European Patent Office(EPO), Japan(JP), and Australia(AU) patent Office are among the top ten patent offices where Amgen is filings its patents. Among the top granted patent authorities, Amgen has 21% of its grants in United States(US), 11% in Japan(JP) and 10% in Israel(IL).

F. Hoffmann-La Roche could be the strongest competitor for Amgen

In terms of grant share, Amgen stands in fifth position among its competitors. Amgen and F. Hoffmann-La Roche secured the top positions according to recent patent publication data.

Patents related to rare diseases and industrial automation lead Amgen's portfolio

Amgen has the highest number of patents in rare diseases followed by, industrial automation and remote patient monitoring. For rare diseases, nearly 35% of patents were filed and 51% of patents were granted in Q1 2024.

Drug delivery devices related patents lead Amgen portfolio followed by pancreatic cancer, and image management

Amgen has highest number of patents in drug delivery devices followed by pancreatic cancer, image management, non-small cell lung cancer, and diabetes. For drug delivery devices, nearly 6% of patents were filed and 5% of patents were granted in Q1 2024.

For comprehensive analysis of Amgen's filings and grants, buy the databook here.

This content was updated on 25 May 2024

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.